Thomas Civik
CIK 1723092 · Interim CEO · last filed 2026-02-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$390.5K
Companies
4
Total Filings
18
Lifetime Open-Market Net
$410.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PYXS | Interim CEO | 221,886 | $1.76 | $390.5K | $200.0K | 7 | 2026-02-05 |
| Repare Therapeutics Inc. (RPTX) Delisted | Director | 0 | $2.65 | $0 | $210.6K | 6 | 2026-01-28 |
| FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | President and CEO | 0 | $38.00 | $0 | $0 | 3 | 2021-04-19 |
| Foundation Medicine, Inc. (FMI) Delisted | Chief Commercial Officer | 33,421 | — | — | $0 | 1 | 2018-01-03 |
Recent Filings · Page 2 of 2
18 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-11-18 | Repare Therapeutics Inc. (RPTX) Delisted | Buy (P) | +7,500 | $210.6K | EDGAR |
| 2021-10-12 | PYXS | Grant (A) | — | $0 | EDGAR |
| 2021-09-09 | Repare Therapeutics Inc. (RPTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-04-19 | FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Disp (D) | −68,971 | -$2.62M | EDGAR |
| 2021-04-13 | FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Tax (F) | −11,088 | -$420.7K | EDGAR |
| 2020-04-14 | FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Grant (A) | +75,000 | $0 | EDGAR |
| 2018-08-02 | — | Other (J) | −33,421 | -$4.58M | |
| 2018-01-03 | Foundation Medicine, Inc. (FMI) Delisted | Grant (A) | +33,421 | $2.28M | EDGAR |
Showing 11–18 of 18
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.